Trexquant Investment LP Morpho Sys Ag Transaction History

Trexquant Investment LP

  • $4.86 Billion
  • Q1 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$4.51 - $7.39 $68,881 - $112,867
-15,273 Closed
0 $0
Q1 2022

May 13, 2022
SELL
$5.87 - $9.73 $28,416 - $47,102
-4,841 Reduced 24.07%
15,273 $104,000
Q4 2021

Feb 14, 2022
BUY
$9.08 - $12.45 $182,635 - $250,419
20,114 New
20,114 $189,000

Others Institutions Holding MOR

# of Institutions
72
Shares Held
11.3M
Call Options Held
320K
Put Options Held
1.1M
View Full List

About MorphoSys AG

MOR Quotes by TradingView
  • Ticker MOR
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 136,614,000
  • Market Cap $2.47B
  • Description
  • MorphoSys AG, a commercial-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapeutic antibodies for patients suffering from cancer and autoimmune diseases in the United States. It offers Tafasitamab, an antibody for the treatment of B cell malignancies, including diffuse large B-cell lymphoma, f...
More about MOR
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email